A safe and feasible “clock-face” duct-to-mucosa pancreaticojejunostomy with a very low incidence of anastomotic failure: A single center experience of 248 patients

Abstract

This modified pancreaticojejunostomy is widely applicable and is associated with very low rates of POPF, low postoperative morbidity and mortality. Overall, it is a feasible and safe novel approach with excellent short-term outcomes.

Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas

“…This limited predictive accuracy presents a challenge as pancreatic resection continues to be associated with a risk of substantial morbidity and mortality. In high-volume centers performing pancreaticoduodenectomy, the reported major morbidity rates are approximately 20% to 30% and mortality rates approximately 2% to 4% (9,10).…”

Non-Whipple Operations in the Management of Benign, Premalignant and Early Cancerous Duodenal Lesions

“…Postoperatively, standardized management included clinical evaluation twice daily and daily analyses of blood and drain-fluid samples as described earlier (62)(63)(64)(65)(66). Postoperative mortality was defined as death occurring within 90 days after surgery or during hospital stay.…”

Pancreaticojejunostomy—a review of modern techniques

“…Papalampros et al performed a similar anastomosis with 12 single interrupted 5-0 or 6-0 sutures for the MPD and performed the outer suture layer with one running double-armed stitch, with very promising results in a large group of patients [36]. Su et al described a 3-layer duct-to-mucosa anastomosis.…”